Trial record 1 of 1 for: NCT03196427
Previous Study | Return to List | Next Study
Long-term Safety With Vedolizumab Intravenous (IV) in Pediatric Participants With Ulcerative Colitis (UC) or Crohn's Disease (CD)
|The safety and scientific validity of this study is the responsibility of the study sponsor and investigators. Listing a study does not mean it has been evaluated by the U.S. Federal Government. Read our disclaimer for details.|
|ClinicalTrials.gov Identifier: NCT03196427|
Recruitment Status : Active, not recruiting
First Posted : June 22, 2017
Last Update Posted : January 8, 2021
Takeda Development Center Americas, Inc.
Takeda Development Centre Europe Ltd.
Information provided by (Responsible Party):
No Study Results Posted on ClinicalTrials.gov for this Study
|Recruitment Status :||Active, not recruiting|
|Estimated Primary Completion Date :||May 25, 2025|
|Estimated Study Completion Date :||May 25, 2025|